Ranbaxy will launch Olmesartan Medoxomil, an antihypertensive that was originally discovered by Daiichi Sankyo, in six African countries. The countries are Kenya, Mozambique, Nigeria, Tanzania, Uganda, and Zambia. The companies will launch the products under the brand name Olvance, as soon as the necessary measures have been completed in each country.
Takashi Shoda, president & CEO of Daiichi Sankyo said, "This is the first time in Africa that Daiichi Sankyo and Ranbaxy are leveraging mutual synergies generated through the hybrid business model."
Share this: 
Del.icio.us |
Email This | 
Printer Friendly
